Expression of snail, twist, and Zeb1 in malignant mesothelioma

APMIS

Volumn 121, Issue 1, 2013, Pages 1-10

  Merikallio, Heta ^a,b   Pääkkö, Paavo ^a   Salmenkivi, Kaisa ^c   Kinnula, Vuokko ^d   Harju, Teihu ^a   Soini, Ylermi ^e  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

EMT; Mesothelioma; Snail; Twist; Zeb1

Indexed keywords

TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIOID CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; NUCLEAR PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR;

EID: 84871666566     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2012.02931.x     Document Type: Article

References (34)

1. Kumar P, Kratzke RA. Molecular prognostic markers in malignant mesothelioma. Lung Cancer. 2005;49:S53-60.
2. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Tumours of the Lung, Pleura, Thymus and Heart. Pathology & Genetics. WHO Classification of Tumours. Lyon: IARC Press, 2004.
3. Johansson L, Lindén CJ. Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas. Chest 1996;109:109-14.
4. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010;15:117-34.
5. Kalluri R, Weisberg RA. The basics of epitheliomesenchymal transition. J Clin Invest 2009;119:1420-8.
6. Meindl-Beinker NM, Dooley S. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis. J Gastroenterol Hepatol 2008;23:S122-7.
7. Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol 2011;73:413-35.
8. De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, Redeuilh G, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol 2008;130:481-94.
9. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin. ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009;28:151-66.
10. Davis-Dusenbery BN, Hata A. MicroRNA in cancer: the involvement of aberrant MicroRNA biogenesis regulatory Pathways. Genes Cancer 2010;1:1100-14.
11. Tuhkanen H, Soini Y, Kosma VM, Anttila M, Sironen R, Hämäläinen K, et al. Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression. BMC Cancer 2009;9:289.
12. Tuhkanen H, Anttila M, Kosma VM, Heinonen S, Juhola M, Helisalmi S, et al. Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas. Int J Cancer 2006;119:1345-53.
13. Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P, et al. Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer 2011;11:73.
14. Spoelstra NS, Manning NG, Higashi Y, Darling D, Singh M, Shroyer KR, et al. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res 2006;66:3893-902.
15. Sayan AE, Griffiths TR, Pal R, Browne GJ, Ruddick A, Yagci T, et al. SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci USA 2009;106:14884-9.
16. Jouppila-Matto A, Tuhkanen H, Soini Y, Pukkila M, Narkio-Mzakela M, Sironen R, et al. Transcription factor snail1 expression and poor survival in pharyngeal squamous cell carcinoma. Histol Histopathol 2011;26:443-9.
17. Abutaily AS, Collins JE, Roche WR. Cadherins, catenins and APC in pleural malignant mesothelioma. J Pathol 2003;201:355-62.
18. Soini Y, Kinnula V, Kahlos K, Paakko P. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol 2006;59:250-4.
19. Wittekind C, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH. TNM Atlas, 5th edn. Heidelberg: UICC Springer, 2004.
20. Franci C, Takkunen M, Dave N, Alameda F, Gomez S, Rodriguez R, et al. Expression of Snail protein in tumor-stroma interface. Oncogene 2006;25:5134-44.
21. Takkunen M, Grenman R, Hukkanen M, Korhonen M, Garcia de Herreros A, Virtanen I. Snail-dependent and -independent epithelial-mesenchymal transition in oral squamous carcinoma cells. J Histochem Cytochem 2006;54:1263-75.
22. Zhang L, Lei W, Wang X, Tang Y, Song J. Glucocorticoid induces mesenchymal-to-epithelial transition and inhibits TGF-β1-induced epithelial-to-mesenchymal transition and cell migration. FEBS Lett 2010;584:4646-54.
23. Kleinberg L, Holth A, Fridman E, Schwartz I, Shih IeM, Davidson B. The diagnostic role of claudins in serous effusions. Am J Clin Pathol 2007;127:928-37.
24. Facchetti F, Gentili F, Lonardi S, Bercich L, Santin A. Claudin-4 in mesothelioma diagnosis. Histopathology 2007;51:261-3.
25. Kuwahara M, Takeda M, Takeuchi Y, Kuwahara M, Harada T, Maita K. Transforming growth factor beta production by spontaneous malignant mesothelioma cell lines derived from Fisher 344 rats. Virchows Arch 2001;438:492-7.
26. Kamp DW. Asbestos-induced lung diseases: an update. Transl Res 2009;153:143-52.
27. Koli K, Myllarniemi M, Vuorinen K, Salmenkivi K, Ryynänen MJ, Kinnula VL, et al. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 2006;169:61-71.
28. Casarsa C, Bassani N, Ambrogi F, Zabucchi G, Boracchi P, Biganzoli E, et al. Epithelial-to-mesenchymal transition, cell polarity and stemness-associated features in malignant pleural mesothelioma. Cancer Lett 2011;302:136-43.
29. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, et al. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008;112:2088-100.
30. Merikallio H, Kaarteenaho R, Paakko P, Lehtonen S, Hirvikoski P, Mäkitaro R, et al. Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins. J Clin Pathol 2011;64:136-40.
31. Kuo KT, Chou TY, Hsu HS, Chen WL, Wang LS. Prognostic Significance of NBS1 and Snail Expression in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2011;10434-011-2043-2. (Accepted)
32. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009;50:1464-74.
33. Shino Y, Watanabe A, Yamada Y, Tanase M, Yamada T, Matsuda M, et al. Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer 1995;76:2193-201.
34. Franco DL, Mainez J, Vega S, Sancho P, Murillo MM, de Frutos CA, et al. Snail1 suppresses TGF-beta-induced apoptosis and is sufficient to trigger EMT in hepatocytes. J Cell Sci 2010;123:3467-77.